Benzingas Top Pre-Market NASDAQ Losers

Pain Therapeutics (NASDAQ: PTIE) dipped 23.96% to $4.03 in the pre-market session. Pfizer (NYSE: PFE) and PTIE received a Complete Response Letter from the US Food and Drug Administration (FDA) on the resubmission to the new drug application (NDA) for REMOXY.

Fundtech Ltd (NASDAQ: FNDT) dropped 0.87% to $19.41 in the pre-market trading. S1 Corp (NASDAQ: SONE) agreed to acquire Fundtech in a stock deal valued at $20.51 per share or about $700 million.

Partner Communications Company Ltd (NASDAQ: PTNR) moved down 0.84% to $15.10 in the pre-market session. PTNR's PEG ratio is 1.29.

Spreadtrum Communications Inc (NASDAQ: SPRD) fell 0.71% to $14 in the pre-market session. SPRD's trailing-twelve-month ROA is 14.17%.